This activity is expired and is no longer available for CME credit.


What Are the Long-Term Effects of Ranibizumab on Diabetic Retinopathy?

Author(s)/Faculty: Michael S. Ip, MD
Release Date: 5/18/2012Expiration Date: 5/17/2015
Credit Type: CMENumber of Credits: 0
Content Type: Provider:
Intravitreal RBZ reduced the risk and rate of DR progression in eyes with DME; additionally, many RBZ-treated eyes experienced improvements in DR severity. Implications of these findings will be discussed...